Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Oracle executive Troy Tazbaz named new FDA director of digital health
3 years ago
Pharma
FDA+
Eric Lander to return to Broad Institute, one year after White House exit over bullying allegations
3 years ago
Amgen lays off about 300 workers, citing 'industry headwinds'
3 years ago
Pharma
Kidney disease drugmaker Goldfinch Bio shuts down
3 years ago
Startups
Dutch biotech starts liquidation after ending PhIII in GVHD
3 years ago
R&D
Pfizer lays off employees at California and Connecticut sites
3 years ago
Pharma
Celularity warns of looming layoffs, spotlights early programs as money runs dry
3 years ago
Investor 'misalignment' leads to tRNA biotech's shuttering
3 years ago
Startups
Abzena lays off more than 60 employees in California
3 years ago
Manufacturing
NIH associate director announces departure to private sector, joining anti-aging biotech
3 years ago
Neuralink employees cite layoffs at Elon Musk’s brain-computer interface startup
3 years ago
Startups
AI
Pioneering biotech icon George Scangos hands in his retirement papers — and this time it’s for real
3 years ago
Bioregnum
A stem cell pioneer sent an experiment into space. Patients are the next frontier
3 years ago
Cell/Gene Tx
In Focus
Finch throws in the towel on microbiome journey, lets go of 77 employees
3 years ago
R&D
Over 130 employees let go from Merck KGaA R&D teams in Massachusetts
3 years ago
VC investor Paul Manning donates $100M to UVA for new R&D institute
3 years ago
Financing
What’s with Bristol Myers’ R&D job cuts in New Jersey? They’re not saying much
3 years ago
Bioregnum
As monotherapy data disappoint, Cyteir lets go of 35 staffers, goes all in on ovarian cancer
3 years ago
Scoop: Just months after Sanofi AI deal, Atomwise laid off 30% of staffers amid 'strategic shift'
3 years ago
Amarin, Sarissa continue playing out activist attack
3 years ago
Akili cuts about 30% of staff in effort to be 'extremely lean'
3 years ago
Pharma
Scoop: Roche-backed startup gives up on CD47, lays off all employees
3 years ago
Startups
Alex Denner targets Amarin, demanding board chair resign in call for shareholder meeting
3 years ago
A Takeda-backed GI and pain biotech quietly shutters
3 years ago
Startups
First page
Previous page
33
34
35
36
37
38
39
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit